Overview
- Telehealth company Hims & Hers said it has a steady stock of estradiol patches and is now providing them to eligible patients through its platform.
- Pharmacies across the United States report uneven availability of patches, while the FDA has not listed the products as officially in shortage.
- Use of patches rose after the FDA removed a black‑box warning last year, and Truveta data cited in reporting show a 26% increase in estrogen therapy prescribing.
- Industry sources told Reuters the supply squeeze could persist for up to three years as demand stays elevated following the shift in health guidance.
- Public figures such as Amy Schumer urged patients to request three‑month refills and to consider other forms of estrogen, including pills, gels or creams, a vaginal ring, and a skin spray.